title: Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome.
abstract: We describe a case of severe CINCA syndrome in a Japanese male infant. We recently managed with anti-interleukin 1 agent (anakinra). Anakinra immediately led to improvement of both the clinical symptoms and the laboratory findings.
authors: Department of Pediatrics, Tokyo Medical University, Tokyo, Japan. hoyohoyo@tokyo-med.ac.jp
authors: Yasuyo
authors: Y
authors: Kashiwagi
authors: Hisashi
authors: H
authors: Kawashima
authors: Shigeo
authors: S
authors: Nishimata
authors: Ryuhei
authors: R
authors: Nagao
authors: Kiyoko
authors: K
authors: Watanabe
authors: Kouji
authors: K
authors: Takekuma
authors: Akinori
authors: A
authors: Hoshika
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D005076:Exanthema / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D012720:Severity of Illness Index; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein